Poised for Breakout with Strong Q4 Results and Strategic Merger

✅ Sun Pharmaceutical Industries is forming a symmetrical triangle pattern with support around INR 1,450 and resistance at INR 1,560. A breakout above 1,560 could signal a strong upward movement towards INR 1,650 and beyond.

✅ Sun Pharma reported a projected net profit increase of 18.4% for Q4 FY24, reaching INR 2,347 crore. The company has also recently secured shareholder approval for its merger with Taro Pharmaceutical Industries, expected to close soon, which will enhance its global market presence and capabilities.